135 related articles for article (PubMed ID: 24100032)
1. Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.
Grishin AA; Cuny H; Hung A; Clark RJ; Brust A; Akondi K; Alewood PF; Craik DJ; Adams DJ
J Biol Chem; 2013 Nov; 288(48):34428-42. PubMed ID: 24100032
[TBL] [Abstract][Full Text] [Related]
2. Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP.
Ulens C; Hogg RC; Celie PH; Bertrand D; Tsetlin V; Smit AB; Sixma TK
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3615-20. PubMed ID: 16505382
[TBL] [Abstract][Full Text] [Related]
3. Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors.
Huynh PN; Harvey PJ; Gajewiak J; Craik DJ; Michael McIntosh J
Biochem Pharmacol; 2020 Nov; 181():114124. PubMed ID: 32593612
[TBL] [Abstract][Full Text] [Related]
4. Potency- and Selectivity-Enhancing Mutations of Conotoxins for Nicotinic Acetylcholine Receptors Can Be Predicted Using Accurate Free-Energy Calculations.
Katz D; DiMattia MA; Sindhikara D; Li H; Abraham N; Leffler AE
Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34202022
[TBL] [Abstract][Full Text] [Related]
5. Molecular Regulation of Betulinic Acid on α3β4 Nicotinic Acetylcholine Receptors.
Lee S; Jung W; Eom S; Yeom HD; Park HD; Lee JH
Molecules; 2021 May; 26(9):. PubMed ID: 34062829
[TBL] [Abstract][Full Text] [Related]
6. Molecular Regulation of α3β4 Nicotinic Acetylcholine Receptors by Lupeol in Cardiovascular System.
Eom S; Kim C; Yeom HD; Lee J; Lee S; Baek YB; Na J; Park SI; Kim GY; Lee CM; Lee JH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570692
[TBL] [Abstract][Full Text] [Related]
7. Cell surface localization of α3β4 nicotinic acetylcholine receptors is regulated by N-cadherin homotypic binding and actomyosin contractility.
Brusés JL
PLoS One; 2013; 8(4):e62435. PubMed ID: 23626818
[TBL] [Abstract][Full Text] [Related]
8. Function of human α3β4α5 nicotinic acetylcholine receptors is reduced by the α5(D398N) variant.
George AA; Lucero LM; Damaj MI; Lukas RJ; Chen X; Whiteaker P
J Biol Chem; 2012 Jul; 287(30):25151-62. PubMed ID: 22665477
[TBL] [Abstract][Full Text] [Related]
9. Dual Antagonism of α9α10 nAChR and GABA
Li X; Tae HS; Chen S; Yousuf A; Huang L; Zhang J; Jiang T; Adams DJ; Yu R
J Med Chem; 2024 Jan; 67(2):971-987. PubMed ID: 38217860
[TBL] [Abstract][Full Text] [Related]
10. Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABA
Tae HS; Ortells MO; Yousuf A; Xu SQ; Akk G; Adams DJ; Arias HR
Biochem Pharmacol; 2024 May; 223():116183. PubMed ID: 38580167
[TBL] [Abstract][Full Text] [Related]
11. An Investigation of Three-Finger Toxin-nAChR Interactions through Rosetta Protein Docking.
Gulsevin A; Meiler J
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32947868
[TBL] [Abstract][Full Text] [Related]
12. Rational Design of Potent α-Conotoxin PeIA Analogues with Non-Natural Amino Acids for the Inhibition of Human α9α10 Nicotinic Acetylcholine Receptors.
Li T; Tae HS; Liang J; Zhang Z; Li X; Jiang T; Adams DJ; Yu R
Mar Drugs; 2024 Feb; 22(3):. PubMed ID: 38535451
[TBL] [Abstract][Full Text] [Related]
13. alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.
Luo S; Kulak JM; Cartier GE; Jacobsen RB; Yoshikami D; Olivera BM; McIntosh JM
J Neurosci; 1998 Nov; 18(21):8571-9. PubMed ID: 9786965
[TBL] [Abstract][Full Text] [Related]
14. What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders.
Straub CJ; Rusali LE; Kremiller KM; Riley AP
J Med Chem; 2023 Jan; 66(1):107-121. PubMed ID: 36440853
[TBL] [Abstract][Full Text] [Related]
15. Marine Origin Ligands of Nicotinic Receptors: Low Molecular Compounds, Peptides and Proteins for Fundamental Research and Practical Applications.
Kasheverov I; Kudryavtsev D; Shelukhina I; Nikolaev G; Utkin Y; Tsetlin V
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204690
[TBL] [Abstract][Full Text] [Related]
16. Interactions of Globular and Ribbon [γ4E]GID with α4β2 Neuronal Nicotinic Acetylcholine Receptor.
Wu X; Craik DJ; Kaas Q
Mar Drugs; 2021 Aug; 19(9):. PubMed ID: 34564144
[TBL] [Abstract][Full Text] [Related]
17. Venom-Derived Neurotoxins Targeting Nicotinic Acetylcholine Receptors.
Bekbossynova A; Zharylgap A; Filchakova O
Molecules; 2021 Jun; 26(11):. PubMed ID: 34204855
[TBL] [Abstract][Full Text] [Related]
18. α-Conotoxin Peptidomimetics: Probing the Minimal Binding Motif for Effective Analgesia.
Kennedy AC; Belgi A; Husselbee BW; Spanswick D; Norton RS; Robinson AJ
Toxins (Basel); 2020 Aug; 12(8):. PubMed ID: 32781580
[TBL] [Abstract][Full Text] [Related]
19. Interactions of the α3β2 Nicotinic Acetylcholine Receptor Interfaces with α-Conotoxin LsIA and its Carboxylated C-terminus Analogue: Molecular Dynamics Simulations.
Wen J; Adams DJ; Hung A
Mar Drugs; 2020 Jul; 18(7):. PubMed ID: 32635340
[TBL] [Abstract][Full Text] [Related]
20. α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
van Hout M; Valdes A; Christensen SB; Tran PT; Watkins M; Gajewiak J; Jensen AA; Olivera BM; McIntosh JM
Neuropharmacology; 2019 Oct; 157():107691. PubMed ID: 31255696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
